Signaling pathways
-
BA8182 DSR-141562Summary: DSR-141562 is a novel, orally active phosphodiesterase inhibitor that crosses the blood-brain barrier. - BA8183 Autotaxin-IN-3Summary: Autotaxin-IN-3 is an inhibitor.
- BA8184 DovramilastSummary: Dovramilast (CC-11050) is a phosphodiesterase 4 inhibitor with oral activity that reduces the inflammatory response and improves mediated lung bacterial clearance.
- BA8185 CarbazeranSummary: Carbazeran is a potent phosphodiesterase inhibitor and is an aldehyde oxidase substrate.
- BA8186 FCPR03Summary: FCPR03 is a potent and selective phosphodiesterase 4 inhibitor.
- BA8187 OglemilastSummary: Oglemilast (GRC3886) is an orally active phosphodiesterase 4 inhibitor.
- BA8188 BRD9500Summary: BRD9500 is a potent, orally active phosphodiesterase 3 inhibitor.
- BA8189 PDE7-IN-3Summary: PDE7-IN-3 is a phosphodiesterase inhibitor with potential analgesic activity.
- BA8190 Enpp-1-IN-16Summary: Enpp-1-IN-16 is an inhibitor.
- BA8191 3-O-MethylquercetinSummary: 3-O-Methylquercetin (3-MQ) is a major component from plants that inhibits total cAMP and.